UroTech products

UroTech is pleased to present lithotripsy by Dornier. Having pioneered extracorporeal shock wave lithotripsy (ESWL) over 15 years ago, Dornier is widely acknowledged as the global leader in shockwave technology.

The Prostatron® System is a non-surgical treatment alternative used to treat BPH in a single, one-half hour session. The treatment is performed on an outpatient basis and requires oral sedation and local anesthesia. No serious long-term side effects are associated with the Prostatron procedure.

The GreenLight PVP™ Procedure is a breakthrough treatment option for BPH performed with an 80-watt KTP laser. The GreenLight PVP™ Procedure combines the `Best of Both Worlds` - it is minimally invasive and it offers the immediate and long lasting results of more aggressive surgical options, such as TURP, TUIP and Open Prostatectomy. What makes this laser wavelength so effective is its absorption by hemoglobin. Because of its high absorption by hemoglobin, the laser completely vaporizes the prostate tissue quickly and seals the blood vessels, thereby causing very little bleeding. The benefit of immediate vaporization is that there is no tissue left behind. Laser energy is delivered through a side-firing, non-contact fiber inserted through a continuous flow cystoscope.

The Prostatron® System is a non-surgical treatment alternative used to treat BPH in a single, one-half hour session. The treatment is performed on an outpatient basis and requires oral sedation and local anesthesia. No serious long-term side effects are associated with the Prostatron procedure. Available in Europe since 1991, Prostatron has been used to treat thousands of patients worldwide. The US Food and Drug Administration (FDA) approved Prostatron in May of 1996 based on the clinical findings of Georgetown University Medical Center, Washington, DC; Rush Presbyterian Hospital in Chicago, IL; Kidney Stone Center in Denver, CO; and the Mayo Clinics in Rochester, MN, and Jacksonville, FL.

Cryoablation is emerging as an effective, minimally invasive treatment for localized prostate cancer. Cryoablation is revolutionizing localized prostate cancer treatment by abolishing the "one shot" treatment method of having only one chance at treating the cancer. When used as a primary method of treatment, cryoablation is repeatable if necessary, or it can be used as a secondary treatment when radiation fails.